Can antimicrobial susceptibility testing results for ciprofloxacin or levofloxacin predict susceptibility to a newer fluoroquinolone, gatifloxacin?: Report from The SENTRY Antimicrobial Surveillance Program (1997

Can antimicrobial susceptibility testing results for ciprofloxacin or levofloxacin predict susceptibility to a newer fluoroquinolone, gatifloxacin?: Report from The SENTRY Antimicrobial Surveillance Program (1997–99)

Published:2001-04 Issue:4 Volume:39 Page:237-243
ISSN:0732-8893
Container-title:Diagnostic Microbiology and Infectious Disease
language:en
Short-container-title:Diagnostic Microbiology and Infectious Disease

Author:

Jones Ronald N.,Pfaller Michael A.

Publisher

Elsevier BV

Subject

Infectious Diseases,Microbiology (medical),General Medicine

Reference18 articles.

1. Cross susceptibility and absence of cross resistance to cefotetan and cefoxitin;Barry;J Clin Microbiol,1987

2. Comparison of the antibacterial activities of the quinolones BAY 12–8039, gatifloxacin (AM-1155), trovafloxacin, clinafloxacin, levofloxacin, and ciprofloxacin;Bauernfeind;J Antimicrob Chemother,1997

3. Levofloxacin;Davis;Drugs,1994

4. Ferraro, M. J., & Jorgensen, J. H. (1995). Instrument-based antibacterial susceptibility testing. p 1379–1384. In: P. R. Murray, E. J. Baron, M. A. Pfaller et al. (eds). Manual of Clinical Microbiology, 6th ed. American Society for Microbiology, Washington, DC.

5. Antibacterial properties of AM-1155, a new 8-methoxy quinolone;Hosaka;J Antimicrob Chemother,1995

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Surrogate analysis of vancomycin to predict susceptible categorization of dalbavancin;Diagnostic Microbiology and Infectious Disease;2015-05

2. Use of In Vitro Vancomycin Testing Results To Predict Susceptibility to Oritavancin, a New Long-Acting Lipoglycopeptide;Antimicrobial Agents and Chemotherapy;2015-04

3. Use of Anidulafungin as a Surrogate Marker To Predict Susceptibility and Resistance to Caspofungin among 4,290 Clinical Isolates of Candida by Using CLSI Methods and Interpretive Criteria;Journal of Clinical Microbiology;2014-06-20

4. Use of Micafungin as a Surrogate Marker To Predict Susceptibility and Resistance to Caspofungin among 3,764 Clinical Isolates of Candida by Use of CLSI Methods and Interpretive Criteria;Journal of Clinical Microbiology;2013-10-23

5. Interim susceptibility testing for ceftaroline, a new MRSA-active cephalosporin: selecting potent surrogate β-lactam markers to predict ceftaroline activity against clinically indicated species;Diagnostic Microbiology and Infectious Disease;2013-01